Jillian B. Thomsen — Chief Accounting Officer and Senior Vice President of Finance at Nektar Therapeutics | Comparably
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform. read more
EMPLOYEE
PARTICIPANTS
9
TOTAL
RATINGS
191
Jillian B. Thomsen — Chief Accounting Officer and Senior Vice President of Finance at Nektar Therapeutics

Jillian B. Thomsen — Chief Accounting Officer and Senior Vice President of Finance at Nektar Therapeutics

Executive Bio

Ms. Jillian B. Thomsen has been Chief Accounting Officer at Nektar Therapeutics since April 21, 2008 and its Senior Vice President of Finance since February 2010. Ms. Thomsen served as Controller of Nektar Therapeutics from March 2006 to April 20, 2008 and also served as its Vice President of Finance from April 2008 to February 2010. Before joining Nektar in March 2006, she served as a Deputy Controller of Calpine Corporation from September 2002 to February 2006. From December 1990 to May 2002, she performed various roles with Arthur Andersen starting as a Staff Accountant and concluding as a Senior Manager. She participates in Nektar's Standard Executive Benefits Program, including its change of control severance benefit plan. Ms. Thomsen holds a Master's of Accountancy from the University of Denver and a B.A. in Business Economics from Colorado College.

Executive Team Culture Ratings from Nektar Therapeutics Employees

BOTTOM
20%
Nektar Therapeutics' Executive Team scores in the Bottom 20%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Nektar Therapeutics
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Nektar Therapeutics

Nektar Therapeutics' Executive Team at a Glance

Based on 8 ratings, Nektar Therapeutics' employees are less satisfied with their Executive Team and give them a ā€œDā€ or 54/100.

Nektar Therapeutics' Executive Team ranks in the Bottom 15% of other companies in San Francisco and Bottom 20% of other companies on Comparably that also have 501-1,000 Employees.

×
Rate your company